Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatoid Arthritis: Time Is of the Essence

Sue Pondrom  |  Issue: June 2008  |  June 1, 2008

“My calculation is that there are probably 75,000 new cases of RA every year in the U.S.,” Dr. Cush says. “If every rheumatologist made an exceptional effort to get those patients, it would mean an extra 20 to 30 patients a year, and they could absorb that with no problem. However, to capture these patients, the rheumatologist will have to see many more patients, as the yield for early inflammatory arthritis is usually less than 10%, even when promoting referral rules to primary-care physicians. You might have to see hundreds of patients with fibromyalgia to get one with early RA. So, why should somebody in practice revamp for what seems to be very little gain?”

Another challenge for rheumatologists is being referred a patient with symptom duration of one to two years. “In the last several years, I don’t remember seeing a patient with true early synovitis,” says Gary Firestein, MD, chief of rheumatology and immunology at the University of California, San Diego School of Medicine.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In the typical RA case, he says, a patient will stay at home and self-medicate for a few months. When there’s finally a doctor visit, the signs and symptoms of inflammatory synovitis may not be recognized; treatment will usually be conservative, perhaps with a non-steroidal anti-inflammatory drug. Another month or so may pass. When the patient returns to the doctor with continuing pain, tests are run and another couple of weeks go by before there’s a referral to the rheumatologist—who may have a wait of two or three months for an appointment.

How Early Is Early?

Although today’s ideal is early treatment, the actual definition of “early” varies. While some advocate treatment as early as three months, others prefer to wait.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“I think we need to be careful and not overtreat a patient with symptoms of joint pain,” says Larry Moreland, MD, professor of medicine at the University of Pittsburgh and formerly at the University of Alabama, Birmingham, who has participated in an EAC. “Often times patients have self-limiting problems and do not require treatment in the first few weeks,” he says, “and in about a third of the cases, the symptoms will resolve without therapy.” He adds that, “what we don’t want is to have a patient with RA go untreated for six to 12 months.”

However, “most PCPs have a hard time making the diagnosis of RA, even if it’s clear RA,” notes Dr. Moreland. “That’s because it often isn’t clear. Patients have vague symptoms. Making an RA diagnosis for me as a rheumatologist is pretty easy. But if you’re out there on the front line where you’re seeing all kinds of problems, it’s not easy.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:clinicDiagnosisDiagnostic CriteriaRheumatoid arthritisTreatment

Related Articles

    Stop the Rheumatoid Arthritis (RA) Cascade Early

    May 1, 2008

    Early arthritis clinics pioneered diagnosis and treatment to prevent disease progression

    Key Studies Highlighted: 2 Industry Veterans Discuss Their Favorite Annual Meeting Abstracts

    March 19, 2020

    ATLANTA—With more than 3,000 abstracts from 103 countries presented at the 2019 ACR/ARP Annual Meeting in November, it was impossible for attendees to view them all. However, two ACR/ARP veterans—Arthur Kavanaugh, MD, from the University of California, San Diego, and John Cush, MD, from UT Southwestern Medical School, Dallas—chose to tackle the nearly impossible task and…

    Tips to Improve Communication with Colleagues & Patients

    October 31, 2019

    Crafting clear and captivating messaging for patients and colleagues isn’t always easy. Here are some tips to improve your approach…

    The Latest Autoinflammatory Discoveries & Tips

    March 17, 2018

    SAN DIEGO—Since the identification of the autoinflammatory disease, familial Mediter­ranean fever (FMF), researchers have identified an alphabet soup of other auto­inflammatory diseases with genetic underpinnings, from PAPA (pyogenic arthritis with pyoderma gangrenosum and acne) to NIAID (NLRP1-associated autoinflammation with arthritis and dyskeratosis) to TRAPS (TNF receptor-associated periodic syndrome). The torrent of discoveries, brought about largely…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences